Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rictor-mTOR protein complex (mTORC2) is a multi-protein complex containing mTOR that integrates signals from nutrients and growth factors to regulate cell growth, metabolism, survival, and cytoskeletal organization. It phosphorylates AGC family kinases such as Akt, SGK1, and certain isoforms of PKC. Unlike mTORC1, mTORC2 contains RICTOR and is generally insensitive to acute rapamycin treatment. Dysregulation of mTORC2 has been implicated in cancer and metabolic diseases.
Phosphorylation/activation of AGC kinases (AKT(Ser473), SGK1, PKC)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rictor-mTOR protein complex (mTORC2).